One of the most researched combinations in the growth hormone pathway is CJC-1295 + Ipamorelin. Why this particular pair, and how is it examined in research? We'll explain.
The information in this article is for educational purposes only and does not constitute medical advice. All products on the site are for research use only.
Two pathways, one goal
The idea behind the combination is to combine two complementary approaches to stimulating the growth hormone axis:
- CJC-1295 — a GHRH analog (the hormone that releases growth hormone).
- Ipamorelin — from the GHRP family, which acts through the ghrelin receptor and is considered relatively "clean" (selective).
Since each acts on a different pathway, research examines whether the combination produces a complementary effect.
Why Ipamorelin specifically?
Ipamorelin is often chosen because it is considered relatively selective in research — that is, with less "noise" on other systems compared to older GHRPs. This makes the pair popular in research contexts.
With DAC or without?
In the combination versions it is common to use CJC without DAC (Mod GRF), for short, focused activity. For the difference between the versions, see the article on CJC-1295 with and without DAC.
Frequently asked questions
What is the difference between GHRH and GHRP?
Two families that stimulate growth hormone through different mechanisms — and are therefore examined together.
How is it reconstituted?
From powder, using bacteriostatic water andour dilution calculator.
For the research product details: CJC-1295 + Ipamorelin. See also What is CJC-1295 and The general guide.
A common question is where to buy peptides in Israel — we've gathered the answer in a single guide.
The information is general and for educational purposes only and does not constitute medical advice. The products are for research use only.
